Skip to content
CancerIndex

Publication

Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials.

Margaret S Pichardo, Aaron K Aragaki, JoAnn E Manson, Kathy Pan, Su Yon Jung, Thomas E Rohan, Reed Mszar, Rowan T Chlebowski

British journal of cancerSep 16, 2026PMID 42749856doi:10.1038/s41416-026-03621-9 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 19, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260919-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Long-term results on liver cancer incidence and mortality are reported from two Women's Health Initiative randomized trials evaluating menopausal hormone therapy. METHODS: 16,608 postmenopausal women with a uterus were randomized to conjugated equine estrogen (CEE) 0.625 mg/d plus…

Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 1

Candidate 1

Registered trialsNCT00000611

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.